Faculty
Ron Bose.jpg

Ron Bose, MD, PhD

Associate Professor
Department of Medicine
Oncology Division
Molecular Oncology
Department of Cell Biology & Physiology

Clinical Interests

  • Her2-positive breast cancer
  • Breast cancer

Research Interests

  • Her2/neu tyrosine kinase
  • Genomics of breast cancer
  • Use of proteomics to study breast cancer cell signaling

Contact

  • 314-747-9308 (tel)
  • 314-747-9320 (fax)
  • 4515 McKinley Research Building, Room 3310 (office)
  • Division of Oncology
    Campus Box 8076
    Washington University Medical School
    660 South Euclid Avenue
    St. Louis, MO 63110
  • Bose lab website

Invited Publications & Book Chapters

  • Chapter 19: Genomic events in breast cancer progression
    Goncalves R, Cakar B, Bose R, Ma CX, Ellis MJ
    In: Diseases of the Breast, 5th edition. Editors: Harris JR, Lippman ME, Morrow M, Osborne CK. Lippincott Williams & Wilkins, Philadelphia. In press
  • Target proteins: bottom-up and top-down proteomics
    Boyne MT II, Bose R
    In: Protein and Peptide Mass Spectrometry in Drug Discovery. Editors: Gross ML, Chen G, Pramanik BN. John Wiley & Sons, New Jersey. 2012, pp 89-100
  • Colorectal cancer
    Bose R
    In: The Washington Manual: Hematology and Oncology Subspecialty Consult (G Pillot, ed), Lippincott Williams & Wilkins, Philadelphia, 2004, pp 150-158
  • Other gastrointestinal malignancies
    Bose R
    In: The Washington Manual: Hematology and Oncology Subspecialty Consult (G Pillot, ed), Lippincott Williams & Wilkins, Philadelphia, 2004, pp 159-165
  • Lymphoma
    Bose R
    In: The Washington Manual: Hematology and Oncology Subspecialty Consult (G Pillot, ed), Lippincott Williams & Wilkins, Philadelphia, 2004, pp 221-228

Electronic Publications

  • ASCO tumor board: HER2 positive breast cancer
    Bose R, Henry NL
    E-published Oct 16, 2013 (university.asco.org/her2-positive-breast-cancer-asco-tumor-board)
  • New drugs for HER2-positive metastatic breast cancer: trastuzumab-DM1, neratinib, and tanespimycin
    Bose R, Van Tine B
    E-Updates in HER1 and HER2 Targeting in Breast Cancer, Volume 3 (MJ Ellis, ed), electronically published on CancerNetwork.com, Nov 12, 2009
  • Advances in our understanding of resistance to trastuzumab
    Bose R, Van Tine B
    E-Updates in HER1 and HER2 Targeting in Breast Cancer, Volume 3 (MJ Ellis, ed), electronically published on CancerNetwork.com, Nov 12, 2009
  • Current and future roles of lapatinib in HER2-positive breast cancer
    Ma C, Bose R
    E-Updates in HER1 and HER2 Targeting in Breast Cancer, Volume 2 (MJ Ellis, ed), electronically published on CancerNetwork.com, Sep 1, 2008